| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transforming Growth Factor beta | 4 | 2024 | 473 | 1.850 |
Why?
|
| Sphingolipids | 5 | 2024 | 34 | 1.700 |
Why?
|
| Corneal Stroma | 9 | 2023 | 79 | 1.550 |
Why?
|
| Sphingosine | 5 | 2024 | 17 | 1.540 |
Why?
|
| Lysophospholipids | 5 | 2024 | 33 | 1.380 |
Why?
|
| Keratoconus | 7 | 2024 | 47 | 1.240 |
Why?
|
| Fibrosis | 3 | 2024 | 421 | 1.060 |
Why?
|
| Cornea | 11 | 2024 | 569 | 0.990 |
Why?
|
| Corneal Injuries | 4 | 2025 | 35 | 0.760 |
Why?
|
| Immunologic Deficiency Syndromes | 6 | 2021 | 216 | 0.730 |
Why?
|
| Signal Transduction | 7 | 2024 | 4720 | 0.730 |
Why?
|
| Blood Group Incompatibility | 2 | 2018 | 27 | 0.700 |
Why?
|
| ABO Blood-Group System | 2 | 2018 | 66 | 0.690 |
Why?
|
| Pelvis | 2 | 2019 | 74 | 0.680 |
Why?
|
| Corneal Diseases | 4 | 2024 | 95 | 0.670 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 10 | 2023 | 1192 | 0.670 |
Why?
|
| Exosomes | 3 | 2025 | 57 | 0.600 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 39 | 0.560 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2016 | 106 | 0.560 |
Why?
|
| Pelvic Neoplasms | 1 | 2017 | 24 | 0.540 |
Why?
|
| Organs at Risk | 1 | 2017 | 42 | 0.540 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 173 | 0.530 |
Why?
|
| Mutation | 9 | 2024 | 6243 | 0.510 |
Why?
|
| Radiation Injuries | 1 | 2017 | 158 | 0.490 |
Why?
|
| Rare Diseases | 3 | 2017 | 208 | 0.470 |
Why?
|
| Granulomatous Disease, Chronic | 3 | 2020 | 70 | 0.460 |
Why?
|
| Fibroblasts | 5 | 2024 | 862 | 0.460 |
Why?
|
| Liver Transplantation | 3 | 2019 | 1103 | 0.460 |
Why?
|
| Transforming Growth Factor beta3 | 3 | 2023 | 8 | 0.450 |
Why?
|
| Humans | 72 | 2025 | 132201 | 0.410 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 3356 | 0.410 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2024 | 79 | 0.390 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2023 | 61 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 2023 | 861 | 0.350 |
Why?
|
| Cells, Cultured | 7 | 2025 | 3046 | 0.330 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2025 | 133 | 0.330 |
Why?
|
| Down Syndrome | 2 | 2023 | 232 | 0.330 |
Why?
|
| Wound Healing | 3 | 2025 | 475 | 0.320 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 272 | 0.290 |
Why?
|
| Infant | 19 | 2023 | 13048 | 0.290 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 749 | 0.280 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 26 | 0.280 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2023 | 193 | 0.280 |
Why?
|
| Heterozygote | 2 | 2022 | 715 | 0.280 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 149 | 0.270 |
Why?
|
| Protein Subunits | 1 | 2018 | 171 | 0.270 |
Why?
|
| Saliva | 2 | 2025 | 133 | 0.270 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 2024 | 77 | 0.270 |
Why?
|
| Child, Preschool | 17 | 2024 | 14735 | 0.260 |
Why?
|
| Male | 31 | 2025 | 64979 | 0.260 |
Why?
|
| Infant, Newborn | 11 | 2023 | 8548 | 0.250 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 157 | 0.250 |
Why?
|
| Genome, Human | 2 | 2018 | 1331 | 0.250 |
Why?
|
| Child | 23 | 2023 | 25783 | 0.250 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 139 | 0.250 |
Why?
|
| Coatomer Protein | 2 | 2016 | 30 | 0.240 |
Why?
|
| Luteinizing Hormone | 2 | 2023 | 136 | 0.230 |
Why?
|
| Syndrome | 4 | 2023 | 1175 | 0.230 |
Why?
|
| Exome | 3 | 2022 | 1087 | 0.230 |
Why?
|
| Virus Diseases | 2 | 2019 | 289 | 0.230 |
Why?
|
| Collagen | 2 | 2023 | 303 | 0.230 |
Why?
|
| Alleles | 2 | 2018 | 1684 | 0.220 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2022 | 91 | 0.220 |
Why?
|
| Female | 29 | 2024 | 70754 | 0.210 |
Why?
|
| Epithelium, Corneal | 1 | 2025 | 171 | 0.210 |
Why?
|
| Diptera | 1 | 2023 | 27 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1418 | 0.210 |
Why?
|
| Gonadotropins | 2 | 2021 | 32 | 0.200 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2023 | 4 | 0.200 |
Why?
|
| Ikaros Transcription Factor | 1 | 2023 | 32 | 0.200 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2023 | 47 | 0.200 |
Why?
|
| Stromal Cells | 2 | 2022 | 304 | 0.200 |
Why?
|
| Motion Perception | 1 | 2023 | 73 | 0.190 |
Why?
|
| Software | 1 | 2017 | 731 | 0.190 |
Why?
|
| Replication Protein A | 1 | 2022 | 10 | 0.190 |
Why?
|
| Estriol | 1 | 2022 | 9 | 0.190 |
Why?
|
| Estrone | 1 | 2022 | 12 | 0.190 |
Why?
|
| Mycobacterium bovis | 1 | 2022 | 32 | 0.190 |
Why?
|
| Blotting, Western | 3 | 2025 | 1080 | 0.190 |
Why?
|
| Cell Movement | 3 | 2025 | 890 | 0.180 |
Why?
|
| Cell Line | 4 | 2021 | 2724 | 0.180 |
Why?
|
| Mammals | 1 | 2023 | 271 | 0.180 |
Why?
|
| Telomere Shortening | 1 | 2022 | 34 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2017 | 1580 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 577 | 0.180 |
Why?
|
| Interferon Type I | 2 | 2021 | 114 | 0.180 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2021 | 11 | 0.180 |
Why?
|
| Fusariosis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2023 | 235 | 0.180 |
Why?
|
| Corneal Keratocytes | 1 | 2021 | 5 | 0.180 |
Why?
|
| Ceramides | 2 | 2022 | 46 | 0.180 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2021 | 10 | 0.180 |
Why?
|
| Cell Shape | 1 | 2021 | 69 | 0.180 |
Why?
|
| Craniofacial Abnormalities | 1 | 2023 | 253 | 0.170 |
Why?
|
| Afibrinogenemia | 1 | 2021 | 10 | 0.170 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 111 | 0.170 |
Why?
|
| Agammaglobulinemia | 1 | 2021 | 44 | 0.170 |
Why?
|
| Aspergillosis | 1 | 2021 | 46 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 554 | 0.170 |
Why?
|
| Receptors, Steroid | 1 | 2022 | 176 | 0.170 |
Why?
|
| Hearing Loss | 1 | 2023 | 212 | 0.170 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2022 | 128 | 0.170 |
Why?
|
| Corneal Ulcer | 1 | 2021 | 54 | 0.170 |
Why?
|
| Protein Isoforms | 2 | 2022 | 422 | 0.170 |
Why?
|
| I-kappa B Kinase | 2 | 2022 | 58 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2021 | 142 | 0.170 |
Why?
|
| Sofosbuvir | 1 | 2020 | 21 | 0.170 |
Why?
|
| Eye Infections, Fungal | 1 | 2021 | 73 | 0.170 |
Why?
|
| Pyrrolidines | 1 | 2020 | 42 | 0.170 |
Why?
|
| Fibrinogen | 1 | 2021 | 157 | 0.160 |
Why?
|
| Telomere | 1 | 2022 | 222 | 0.160 |
Why?
|
| Quinoxalines | 1 | 2020 | 38 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2018 | 126 | 0.160 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2017 | 899 | 0.160 |
Why?
|
| Anaphylaxis | 1 | 2021 | 87 | 0.160 |
Why?
|
| Young Adult | 11 | 2024 | 9965 | 0.160 |
Why?
|
| Base Sequence | 2 | 2018 | 2900 | 0.160 |
Why?
|
| Eye Diseases | 1 | 2021 | 116 | 0.160 |
Why?
|
| Benzimidazoles | 1 | 2020 | 132 | 0.150 |
Why?
|
| Cytokines | 4 | 2022 | 1365 | 0.150 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2019 | 1 | 0.150 |
Why?
|
| Vaccines, Attenuated | 1 | 2019 | 176 | 0.150 |
Why?
|
| Women's Rights | 1 | 2018 | 5 | 0.150 |
Why?
|
| Abnormal Karyotype | 1 | 2018 | 8 | 0.150 |
Why?
|
| Microcephaly | 1 | 2022 | 354 | 0.150 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2019 | 22 | 0.150 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1094 | 0.150 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2019 | 23 | 0.150 |
Why?
|
| Graft Rejection | 2 | 2023 | 559 | 0.150 |
Why?
|
| Premature Birth | 1 | 2023 | 418 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 263 | 0.150 |
Why?
|
| Chorionic Villi Sampling | 1 | 2018 | 46 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 3 | 2018 | 1803 | 0.150 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2018 | 32 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 196 | 0.150 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 1177 | 0.140 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 99 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2020 | 284 | 0.140 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 65 | 0.140 |
Why?
|
| Abdomen | 1 | 2019 | 135 | 0.140 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2019 | 73 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 382 | 0.140 |
Why?
|
| Adolescent | 14 | 2022 | 20557 | 0.140 |
Why?
|
| Arthritis | 2 | 2016 | 86 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2018 | 117 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 23 | 0.140 |
Why?
|
| Phenotype | 4 | 2018 | 4538 | 0.140 |
Why?
|
| Alemtuzumab | 1 | 2018 | 88 | 0.140 |
Why?
|
| Cell Extracts | 1 | 2017 | 13 | 0.140 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 84 | 0.140 |
Why?
|
| Chromatin | 1 | 2021 | 519 | 0.140 |
Why?
|
| Schools, Medical | 1 | 2018 | 122 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2021 | 712 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 673 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 613 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2018 | 343 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2019 | 312 | 0.130 |
Why?
|
| Paramyxoviridae Infections | 1 | 2017 | 49 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2022 | 550 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2018 | 239 | 0.130 |
Why?
|
| Metapneumovirus | 1 | 2017 | 52 | 0.130 |
Why?
|
| Trisomy | 3 | 2023 | 112 | 0.130 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 201 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 251 | 0.130 |
Why?
|
| Adult | 14 | 2024 | 31600 | 0.130 |
Why?
|
| Faculty, Medical | 2 | 2018 | 277 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 426 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 2019 | 180 | 0.130 |
Why?
|
| Transcription Factors | 1 | 2016 | 2490 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2018 | 2679 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3139 | 0.130 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 559 | 0.130 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 430 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2023 | 875 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2017 | 856 | 0.130 |
Why?
|
| Retrospective Studies | 9 | 2023 | 17391 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 178 | 0.120 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2016 | 10 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2018 | 494 | 0.120 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 302 | 0.120 |
Why?
|
| Hepatitis C, Chronic | 1 | 2020 | 370 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2022 | 556 | 0.120 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2016 | 31 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 569 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 946 | 0.120 |
Why?
|
| Immunization, Passive | 1 | 2016 | 128 | 0.120 |
Why?
|
| Enteritis | 1 | 2016 | 52 | 0.120 |
Why?
|
| Exons | 1 | 2018 | 806 | 0.120 |
Why?
|
| Autoimmunity | 2 | 2019 | 181 | 0.120 |
Why?
|
| Dendritic Cells | 2 | 2021 | 448 | 0.110 |
Why?
|
| Golgi Apparatus | 1 | 2015 | 95 | 0.110 |
Why?
|
| Family | 1 | 2018 | 595 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 5410 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2020 | 823 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2021 | 1757 | 0.110 |
Why?
|
| Inflammation | 2 | 2019 | 1520 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 191 | 0.100 |
Why?
|
| Animals | 6 | 2025 | 34842 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 898 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 175 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2014 | 136 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2024 | 13028 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 608 | 0.100 |
Why?
|
| Estrogen Receptor beta | 2 | 2023 | 78 | 0.090 |
Why?
|
| Caliciviridae Infections | 1 | 2016 | 361 | 0.090 |
Why?
|
| Chemokines | 1 | 2012 | 130 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 351 | 0.090 |
Why?
|
| Pregnancy, Twin | 2 | 2023 | 190 | 0.090 |
Why?
|
| Middle Aged | 9 | 2024 | 29007 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 2024 | 169 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2018 | 1099 | 0.090 |
Why?
|
| DiGeorge Syndrome | 1 | 2011 | 82 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 232 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2010 | 11 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 385 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 133 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2010 | 141 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 2 | 2023 | 439 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 373 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 2669 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4690 | 0.070 |
Why?
|
| Enterobacteriaceae | 1 | 2008 | 41 | 0.070 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2008 | 56 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 375 | 0.070 |
Why?
|
| Genitalia | 1 | 2016 | 38 | 0.070 |
Why?
|
| Biopsy | 2 | 2023 | 1287 | 0.060 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.060 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 110 | 0.060 |
Why?
|
| Genotype | 2 | 2017 | 2702 | 0.060 |
Why?
|
| Speech Disorders | 1 | 2016 | 48 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 135 | 0.060 |
Why?
|
| Zinc Fingers | 1 | 2016 | 122 | 0.060 |
Why?
|
| Whole Genome Sequencing | 2 | 2018 | 327 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2021 | 799 | 0.060 |
Why?
|
| Muscle Hypotonia | 1 | 2016 | 199 | 0.060 |
Why?
|
| Education, Professional | 1 | 2005 | 11 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2025 | 23 | 0.060 |
Why?
|
| Community Networks | 1 | 2005 | 33 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 540 | 0.060 |
Why?
|
| Ataxia | 1 | 2016 | 177 | 0.060 |
Why?
|
| Receptors, LHRH | 1 | 2024 | 13 | 0.060 |
Why?
|
| Pregnancy | 3 | 2023 | 7557 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2016 | 283 | 0.060 |
Why?
|
| Information Dissemination | 1 | 2017 | 200 | 0.060 |
Why?
|
| Cross Infection | 1 | 2008 | 343 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2017 | 502 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1964 | 0.050 |
Why?
|
| Receptors, Kisspeptin-1 | 1 | 2023 | 1 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 4758 | 0.050 |
Why?
|
| Crown-Rump Length | 1 | 2023 | 7 | 0.050 |
Why?
|
| Twins, Dizygotic | 1 | 2023 | 46 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2019 | 408 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2017 | 662 | 0.050 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2023 | 19 | 0.050 |
Why?
|
| Busulfan | 1 | 2023 | 43 | 0.050 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2023 | 16 | 0.050 |
Why?
|
| Erythrocyte Count | 1 | 2003 | 24 | 0.050 |
Why?
|
| Breast Diseases | 1 | 2023 | 38 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2019 | 5173 | 0.050 |
Why?
|
| Metabolomics | 1 | 2017 | 479 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 124 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2003 | 52 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2022 | 15 | 0.050 |
Why?
|
| Sodium Hydroxide | 1 | 2022 | 7 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1404 | 0.050 |
Why?
|
| Uridine | 1 | 2022 | 32 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 37 | 0.050 |
Why?
|
| Mitochondria | 1 | 2018 | 749 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2023 | 132 | 0.050 |
Why?
|
| Photic Stimulation | 1 | 2023 | 234 | 0.050 |
Why?
|
| Visual Fields | 1 | 2023 | 145 | 0.050 |
Why?
|
| Transposases | 1 | 2022 | 44 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 237 | 0.050 |
Why?
|
| Mice | 3 | 2025 | 18504 | 0.050 |
Why?
|
| Collagen Type V | 1 | 2021 | 4 | 0.040 |
Why?
|
| Survival Rate | 2 | 2017 | 2196 | 0.040 |
Why?
|
| Nerve Tissue | 1 | 2021 | 6 | 0.040 |
Why?
|
| Birth Weight | 1 | 2023 | 351 | 0.040 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 9 | 0.040 |
Why?
|
| Collagen Type III | 1 | 2021 | 26 | 0.040 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 12 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2022 | 112 | 0.040 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2021 | 17 | 0.040 |
Why?
|
| Eye | 1 | 2023 | 235 | 0.040 |
Why?
|
| Aspergillus fumigatus | 1 | 2021 | 44 | 0.040 |
Why?
|
| Fusarium | 1 | 2021 | 13 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 257 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2005 | 416 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 136 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2023 | 426 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2021 | 63 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2021 | 121 | 0.040 |
Why?
|
| Hormones | 1 | 2021 | 170 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 95 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2016 | 982 | 0.040 |
Why?
|
| Health Personnel | 1 | 2005 | 545 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 198 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 293 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2023 | 635 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 287 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 495 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 261 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 268 | 0.040 |
Why?
|
| Corneal Transplantation | 1 | 2019 | 45 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 552 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2021 | 323 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 280 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 224 | 0.040 |
Why?
|
| Genomics | 2 | 2018 | 1652 | 0.040 |
Why?
|
| Monosomy | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2023 | 671 | 0.040 |
Why?
|
| Polyploidy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2019 | 78 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 410 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 749 | 0.040 |
Why?
|
| Metabolome | 1 | 2021 | 324 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2023 | 631 | 0.040 |
Why?
|
| Radiotherapy Dosage | 1 | 2019 | 237 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2022 | 682 | 0.040 |
Why?
|
| Chimerism | 1 | 2018 | 29 | 0.040 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2018 | 31 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 543 | 0.040 |
Why?
|
| Pancytopenia | 1 | 2018 | 40 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 794 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2018 | 143 | 0.040 |
Why?
|
| Unrelated Donors | 1 | 2018 | 70 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 373 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2025 | 2511 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 338 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 826 | 0.030 |
Why?
|
| Granzymes | 1 | 2017 | 48 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 1037 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2023 | 1009 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 2017 | 52 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 68 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2019 | 249 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3414 | 0.030 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2017 | 11 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2017 | 35 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 167 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 196 | 0.030 |
Why?
|
| Homeostasis | 1 | 2021 | 722 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 551 | 0.030 |
Why?
|
| Glucose | 1 | 2021 | 871 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 203 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1295 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2019 | 301 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 1125 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2021 | 784 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 67 | 0.030 |
Why?
|
| Sepsis | 1 | 2020 | 516 | 0.030 |
Why?
|
| Stem Cells | 1 | 2021 | 733 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 356 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 956 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 307 | 0.030 |
Why?
|
| Lod Score | 1 | 2015 | 128 | 0.030 |
Why?
|
| Duodenum | 1 | 2016 | 113 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 539 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1980 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 666 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1354 | 0.030 |
Why?
|
| Incidence | 2 | 2018 | 3377 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 821 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 221 | 0.030 |
Why?
|
| Viral Load | 1 | 2016 | 408 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 370 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 459 | 0.030 |
Why?
|
| Neurons | 1 | 2023 | 2008 | 0.030 |
Why?
|
| Aminosalicylic Acids | 1 | 2012 | 2 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 12 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1128 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 54 | 0.020 |
Why?
|
| Prevalence | 2 | 2011 | 2663 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2018 | 700 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6569 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3402 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1461 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2016 | 490 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 1723 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 5015 | 0.020 |
Why?
|
| United States | 1 | 2017 | 11675 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 306 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 1045 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6452 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 622 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1034 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 1830 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2010 | 36 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 689 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3771 | 0.020 |
Why?
|
| Pediatrics | 1 | 2019 | 1210 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 1285 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 310 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 142 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2920 | 0.020 |
Why?
|
| Aged | 2 | 2018 | 21456 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2851 | 0.020 |
Why?
|
| District of Columbia | 1 | 2008 | 17 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 24 | 0.020 |
Why?
|
| Intensive Care, Neonatal | 1 | 2008 | 57 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 146 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2553 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1350 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2008 | 149 | 0.020 |
Why?
|
| Infection Control | 1 | 2008 | 157 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1611 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1733 | 0.020 |
Why?
|
| Commonwealth of Independent States | 1 | 2005 | 1 | 0.010 |
Why?
|
| International Agencies | 1 | 2005 | 30 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1554 | 0.010 |
Why?
|
| Neoplasms | 1 | 2019 | 2961 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2005 | 163 | 0.010 |
Why?
|
| Schools | 1 | 2005 | 236 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 780 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10944 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2003 | 98 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 70 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 765 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 1171 | 0.010 |
Why?
|